Your browser doesn't support javascript.
loading
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.
Behr, Juergen; Salisbury, Margaret L; Walsh, Simon L F; Podolanczuk, Anna J; Hariri, Lida P; Hunninghake, Gary M; Kolb, Martin; Ryerson, Christopher J; Cottin, Vincent; Beasley, Mary B; Corte, Tamera; Glanville, Allan R; Adegunsoye, Ayodeji; Hogaboam, Cory; Wuyts, Wim A; Noth, Imre; Oldham, Justin M; Richeldi, Luca; Raghu, Ganesh; Wells, Athol U.
Afiliação
  • Behr J; Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany.
  • Salisbury ML; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Walsh SLF; National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Podolanczuk AJ; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.
  • Hariri LP; Department of Pathology and.
  • Hunninghake GM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, and.
  • Kolb M; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ryerson CJ; Firestone Institute for Respiratory Health, St. Joseph's Healthcare and McMaster University, Hamilton, Ontario, Canada.
  • Cottin V; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Beasley MB; Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
  • Corte T; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Glanville AR; Royal Prince Alfred Hospital and.
  • Adegunsoye A; University of Sydney, Sydney, New South Wales, Australia.
  • Hogaboam C; St. Vincent's Hospital, Sydney, New South Wales, Australia.
  • Wuyts WA; Section of Pulmonary and Critical Care, Department of Medicine, and.
  • Noth I; Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois.
  • Oldham JM; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Richeldi L; Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.
  • Raghu G; Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
  • Wells AU; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.
Am J Respir Crit Care Med ; 210(4): 392-400, 2024 Aug 15.
Article em En | MEDLINE | ID: mdl-38484133
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Inflamação Limite: Humans Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Inflamação Limite: Humans Idioma: En Revista: Am J Respir Crit Care Med Assunto da revista: TERAPIA INTENSIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha